Search results
Results from the WOW.Com Content Network
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.
CBRN disposal technicians taking part in a training exercise. Chemical, biological, radiological, and nuclear defense (CBRN defense) or Nuclear, biological, and chemical protection (NBC protection) is a class of protective measures taken in situations where chemical, biological, radiological, or nuclear (including terrorism) hazards may be present.
The Chemical Biological Incident Response Force (CBIRF) is a Marine Corps unit responsible for countering the effects of a chemical, biological, radiological, nuclear, or high-yield explosive (CBRNE) incident, support counter CBRN terrorism, and urban search and rescue when CBRN incident.
Under the plan, the Department of Health and Human Services will be authorized to invest in “domestic manufacturing of essential medicines, medical countermeasures, and critical inputs that have ...
Medical countermeasures (MCMs) are products such as biologics and pharmaceutical drugs that can protect from or treat the effects of a chemical, biological, radiological, or nuclear (CBRN) attack, or in the case of public health emergencies. MCMs can also be used for prevention and diagnosis of symptoms associated with CBRN attacks or threats. [12]
In the United States, EUAs are authorized by Section 564 of the Federal Food Drug and Cosmetic Act (FDCA) of 1938 (Public Law 75-717) as added and subsequently amended by the Project BioShield Act of 2004 (S. 15, Public Law 108–276) for funding of the development and procurement of medical countermeasures against CBRN threats, the Pandemic and All-Hazards Preparedness Reauthorization Act of ...
These contract modifications will help ensure continued supply/stockpiling of critical medical countermeasures to address biological threats and emergencies against anthrax, smallpox, and botulism
This was a ten-year program to acquire medical countermeasures to biological, chemical, radiological and nuclear agents for civilian use. A key element of the Act was to allow stockpiling and distribution of vaccines that had not been tested for safety or efficacy in humans, due to ethical concerns. Efficacy of these agents cannot be directly ...